newsfilter
← Latest News
GlobeNewswire·

Acer Therapeutics Issues Statement Regarding PDUFA Target Action Date for ACER-001

NEWTON, Mass., June 07, 2022 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (NASDAQ:ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant u